Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Nursing Home COVID-19 Survivors Do Not Face Increased Risk of Death After Recovery: Study Severe malnutrition and disability were better predictors of mortality, while getting the COVID-19 vaccine was linked to a better chance of survival. August 2, 2024 Martha Garcia Add Your Comments After nursing homes were hard hit by the COVID-19 pandemic several years ago, some health experts anticipated that even surviving early COVID infections would lead to worse long-term outcomes for nursing home residents. However, the findings of a new study suggests that is not the case. In a report published in the medical journal BMC Geriatrics on August 1, French researchers indicate that surviving a COVID-19 infection during the first wave of the pandemic did not increase nursing home residents’ risk of dying in the next two years. Instead, it appears to have offered some immunity during the next wave of the pandemic. U.S. Nursing Homes Hit Hard by COVID Nursing homes were disproportionately affected by the COVID-19 pandemic, with high rates of infections and deaths. Although the pandemic has largely subsided, data suggests that nursing homes continue to be plagued by a lack of staffing, high turnover rates, and a lack of infectious disease protocols, which could have prevented many of the deadly COVID-19 infection outbreaks. A recent study published by researchers from Pennsylvania State University indicates nursing homes still lack infection control measures four years after the outbreak began, such as personal protective equipment and early isolation for infected patients. Research published in 2022 indicates the high rates of deaths in nursing homes were linked to widespread staffing shortages in nursing homes and long-term care facilities. Early Infections May Have Granted Protection In this new study, French researchers from the Paris Cité University, led by Manuel Sanchez, studied the value of nursing home residents having a COVID-19 infection during the first wave and how that related to an increased risk of death within the next two years. Researchers conducted a retrospective study in three nursing homes in France among 315 nursing home residents who survived the first COVID-19 wave from March to May 2020. Overall, 35% contracted COVID-19 and 9% were hospitalized for it. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Nursing home residents infected with COVID during the first wave of the pandemic often became frailer and more malnourished due to the side effects of the infection. Researchers thought this would lead to a higher rate of death within two years of the infection. However, after analyzing the data, Sanchez’s team discovered nursing home residents who survived a coronavirus infection during the first wave faced no greater risk of death within the next two years than those who avoided an infection. Instead, factors like older age, severe disability, and severe malnutrition were more likely to lead to an increased death risk within the two years after infection. The researchers determined the first wave offered some immunity to nursing home residents who became infected early on. This helped them to have a lower likelihood of dying in the next two years, as did getting the vaccine. “Having survived a COVID-19 infection during the (first COVID-19 pandemic wave) did not affect subsequent 2-year survival in older adults living in NHs,” Sanchez’s team concluded. “Severe malnutrition and disability remained strong predictor of mortality in this population, whereas vaccination was associated to better survival.” Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Coronavirus, COVID-19, Infections, Nursing Home, Nursing Home Neglect, Vaccine More Lawsuit Stories Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 December 2, 2025 Lyft Opposes MDL for Driver Sexual Assault Lawsuits in Federal Court December 2, 2025 Tesla Powerwall Recall Results in Class Action Lawsuit December 2, 2025 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: yesterday) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025) Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 2 days ago) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025) Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 1 week ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 December 2, 2025
Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: yesterday) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)
Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 2 days ago) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025)
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 1 week ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)